Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis

Fig. 2

The frequency of NKT cells in the peripheral blood of CTD-IP patients is increased accompanied by reduction of Tregs. a Gating on lymphocytes, flow cytometric analysis of CD3+ CD4+ T cells, CD3+ CD8+ T cells and CD3+ CD56+ cells in the peripheral blood of healthy controls and patients with CTD-IP. b–e) scatter plots of the percentage of CD3+ CD4+ T cells, CD3+ CD8+ T cells and CD3+ CD56+ cells gating on lymphocytes, and CD25+ FOXP3+ cells gating on CD4+ cells in the peripheral blood of healthy controls (n = 23) and patients with CTD-IP (n = 28). * P < 0.05, ** P < 0.01 for all comparisons between CTD-IP and control. NKT natural killer T cells, CTD-IP interstitial pneumonia in connective tissue disease, Tregs regulatory T cells

Back to article page